Current funding opportunities

You are here

We are now accepting applications for the following funding programs:

Committee for Pharmaceutical Development

Deadline
N/A (applications accepted on a continuous basis)

Program overview
The goal of the Committee for Pharmaceutical Development (CPD) is to identify, develop, and commercialize pharmaceutical products by forming networks and fostering dialogue between University of Minnesota researchers and industry experts. The CPD aims to boost the success rate of therapeutic development and commercialization. 

The Office of the Vice President for Research and the Office of the Vice President for Health Sciences serve as the sponsors of the CPD, which includes University staff and external advisors with proven drug-development experience.

The CPD provides guidance and funding, with potential matching funds from philanthropic and industry partners. Funded technologies will have demonstrated persuasive indicators of commercial success and will show potential for improving human health.

Application instructions
Funding request form
Guidance request form
Please submit forms to the Program Manager, Jodi Fenlon Rebuffoni, at fenl0003@umn.edu
Community Research Van

Deadline
N/A (applications accepted on a continuous basis)

Program overview
Researchers can now access CTSI’s Community Research Van, a new mobile health lab designed to help University of Minnesota research teams conduct health studies in the five-state area.

The van is available at no cost to researchers, and features a laptop, space for private interviews, and equipment for measuring height, weight, cholesterol, heart rates, body composition, and blood sugar. Requests to use the van will be accepted on a continuous basis from researchers who wish to conduct studies that address human health issues.

Application instructions

  • © 2016 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer. Privacy
  • Last modified on April 30, 2016